Metropolitan Life Insurance Company (MetLife)’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,242
| Closed | -$18K | – | 390 |
|
|
2024
Q1 | $18K | Sell |
1,242
-913
| -42% | -$13.2K | ﹤0.01% | 1911 |
|
|
2023
Q4 | $19.8K | Hold |
2,155
| – | – | ﹤0.01% | 1928 |
|
|
2023
Q3 | $35.6K | Buy |
2,155
+356
| +20% | +$5.87K | ﹤0.01% | 1584 |
|
|
2023
Q2 | $11.4K | Buy |
+1,799
| New | +$11.4K | ﹤0.01% | 2232 |
|
|
2023
Q1 | – | Sell |
-2,026
| Closed | -$11.7K | – | 2334 |
|
|
2022
Q4 | $11.7K | Sell |
2,026
-10
| -0.5% | -$58 | ﹤0.01% | 2234 |
|
|
2022
Q3 | $19.1K | Hold |
2,036
| – | – | ﹤0.01% | 2050 |
|
|
2022
Q2 | $45.4K | Hold |
2,036
| – | – | ﹤0.01% | 1566 |
|
|
2022
Q1 | $112K | Sell |
2,036
-6,557
| -76% | -$361K | ﹤0.01% | 1124 |
|
|
2021
Q4 | $568K | Hold |
8,593
| – | – | 0.01% | 1338 |
|
|
2021
Q3 | $721K | Buy |
8,593
+126
| +1% | +$10.6K | 0.01% | 1191 |
|
|
2021
Q2 | $1.07M | Buy |
8,467
+537
| +7% | +$68.2K | 0.02% | 957 |
|
|
2021
Q1 | $870K | Buy |
7,930
+707
| +10% | +$77.6K | 0.01% | 1057 |
|
|
2020
Q4 | $1.03M | Sell |
7,223
-724
| -9% | -$103K | 0.02% | 857 |
|
|
2020
Q3 | $561K | Hold |
7,947
| – | – | 0.01% | 1141 |
|
|
2020
Q2 | $556K | Buy |
7,947
+3,146
| +66% | +$220K | 0.01% | 1128 |
|
|
2020
Q1 | $168K | Sell |
4,801
-5
| -0.1% | -$175 | ﹤0.01% | 1692 |
|
|
2019
Q4 | $302K | Hold |
4,806
| – | – | ﹤0.01% | 1634 |
|
|
2019
Q3 | $161K | Buy |
4,806
+3,758
| +359% | +$126K | ﹤0.01% | 2023 |
|
|
2019
Q2 | $27.2K | Buy |
+1,048
| New | +$27.2K | ﹤0.01% | 2566 |
|